Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q3 EPS of ($1.38), $0.85 worse than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.